A recent study evaluated the use of an artificial pancreas system by people with type 1 diabetes. The study involved 43 participants, who used the system for six months. The artificial pancreas is an automated system that regulates blood glucose levels by administering insulin or glucagon as needed. The participants experienced significantly fewer episodes of hypoglycemia and hyperglycemia compared to when they self-managed their diabetes. The artificial pancreas also allowed them to achieve more time in target glycemic range. The participants reported a reduction in diabetes-related distress and burden as well as improved quality of life. The authors conclude that the use of an artificial pancreas system could be an effective tool to reduce the disease management burden for people with type 1 diabetes.